Skip Navigation


JAC Advance Access originally published online on January 14, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/2/361    most recent
dkg095v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Harmoinen, J.
Right arrow Articles by Westermarck, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harmoinen, J.
Right arrow Articles by Westermarck, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 361-365
© 2003 The British Society for Antimicrobial Chemotherapy

Enzymic degradation of a ß-lactam antibiotic, ampicillin, in the gut: a novel treatment modality

Jaana Harmoinen1,*, Kirsi Vaali2, Pertti Koski3, Kaisa Syrjänen3, Outi Laitinen1, Kai Lindevall3 and Elias Westermarck1

1 Faculty of Veterinary Medicine, Department of Clinical Veterinary Sciences, PO Box 57, Helsinki; 2 Institute of Biomedicine/Pharmacology, PO Box 63, University of Helsinki, FIN-00014 Helsinki; 3 Ipsat Therapies Ltd, Sinimäentie 10B, FIN-02630 Espoo, Finland

Received 8 August 2002; returned 29 October 2002; revised 12 November 2002; accepted 20 November 2002

Antibiotics can cause severe alterations in the gut microflora and promote diarrhoea and overgrowth of pathogenic bacteria. The present study investigated the potency of targeted recombinant ß-lactamase (TRBL) to degrade a ß-lactam antibiotic in the jejunum of fistula-operated beagles. We used different peroral doses of purified ß-lactamase (PenP) of Bacillus licheniformis in enteric-coated pellets together with intravenous ampicillin. Serum and jejunal samples were collected for ampicillin and ß-lactamase analysis. A dose–response effect of TRBL on ampicillin concentrations in the jejunal samples could be observed. The highest doses applied decreased the jejunal ampicillin concentrations to undetectable levels. In the serum samples, the ampicillin concentrations were not affected by the ß-lactamase dose used. Our results indicate that it may be possible to evolve a targeted treatment to degrade ß-lactam antibiotics intestinally and, thus, decrease antibiotic-induced adverse effects on the gut microflora.

Keywords: ß-lactamase, ß-lactams, jejunum, microflora

* Corresponding author. Tel: +358-9-191-49551; Fax: +358-9-191-49670; E-mail: jaana.harmoinen{at}helsinki.fi


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A.-M. Tarkkanen, T. Heinonen, R. Jogi, S. Mentula, M. E. van der Rest, C. J. Donskey, T. Kemppainen, K. Gurbanov, and C. E. Nord
P1A Recombinant {beta}-Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2455 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Harmoinen, S. Mentula, M. Heikkila, M. van der Rest, P. J. Rajala-Schultz, C. J. Donskey, R. Frias, P. Koski, N. Wickstrand, H. Jousimies-Somer, et al.
Orally Administered Targeted Recombinant Beta-Lactamase Prevents Ampicillin-Induced Selective Pressure on the Gut Microbiota: a Novel Approach to Reducing Antimicrobial Resistance
Antimicrob. Agents Chemother., January 1, 2004; 48(1): 75 - 79.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.